Armata Pharmaceuticals (ARMP) Total Current Liabilities: 2013-2018
Historic Total Current Liabilities for Armata Pharmaceuticals (ARMP) over the last 5 years, with Sep 2018 value amounting to $2.5 million.
- Armata Pharmaceuticals' Total Current Liabilities fell 0.48% to $2.5 million in Q3 2018 from the same period last year, while for Sep 2018 it was $2.5 million, marking a year-over-year decrease of 0.48%. This contributed to the annual value of $2.0 million for FY2017, which is 44.38% down from last year.
- According to the latest figures from Q3 2018, Armata Pharmaceuticals' Total Current Liabilities is $2.5 million, which was up 20.30% from $2.0 million recorded in Q2 2018.
- Over the past 5 years, Armata Pharmaceuticals' Total Current Liabilities peaked at $3.7 million during Q2 2017, and registered a low of $1.0 million during Q1 2014.
- For the 3-year period, Armata Pharmaceuticals' Total Current Liabilities averaged around $2.7 million, with its median value being $2.7 million (2016).
- As far as peak fluctuations go, Armata Pharmaceuticals' Total Current Liabilities soared by 106.82% in 2015, and later slumped by 44.79% in 2018.
- Quarterly analysis of 5 years shows Armata Pharmaceuticals' Total Current Liabilities stood at $1.9 million in 2014, then increased by 27.68% to $2.4 million in 2015, then skyrocketed by 48.34% to $3.5 million in 2016, then plummeted by 44.38% to $2.0 million in 2017, then dropped by 0.48% to $2.5 million in 2018.
- Its Total Current Liabilities stands at $2.5 million for Q3 2018, versus $2.0 million for Q2 2018 and $1.8 million for Q1 2018.